Vi Management Ventures Sanderling Net Worth & Insider Trades

Vi Management Ventures Sanderling - Director, Pacira Pharmaceuticals, Inc

As of March 20, 2013

What is Vi Management Ventures Sanderling's Net Worth?

The current estimated net worth of Pacira Pharmaceuticals, Inc's Director, Vi Management Ventures Sanderling, is estimated to be about $33.81M . Vi Management Ventures Sanderling owns about 416,083 units of Pacira Pharmaceuticals, Inc common stock. In the last 2 years at Pacira Pharmaceuticals, Inc, Vi Management Ventures Sanderling has sold an estimated value of $16.52M worth.

What is Vi Management Ventures Sanderling's Past Insider Trading?

Vi Management Ventures Sanderling's largest purchase order was 221,478 units , worth over $1.55M on February 10, 2011. Vi Management Ventures Sanderling's largest sale order was 598,596 units , worth over $9.46M on January 25, 2013. In total, Vi Management Ventures Sanderling has made about 5 transactions over 2 years of their time at Pacira Pharmaceuticals, Inc. Vi Management Ventures Sanderling usually trades in February and March, with the busiest year in 2013. The most recent transaction was a sale order of 450,000 units , worth over $7.05M on March 20, 2013.

Sanderling Venture Partners VI LP, KG Co GmbH Beteiligungs VI Sanderling, VI Management Ventures Sanderling, Partnership Limited VI Sanderling, Sanderling Venture Partners VI Co Investment Fund LP, FRED MIDDLETON

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Vi Management Ventures Sanderling's' Mailing Address?

  • Mailing address is 400 S. el Camino Real, Suite 1200 San Mateo CA 94402 CA

What are Pacira Pharmaceuticals, Inc's Past Insider Trades?

Pacira Pharmaceuticals, Inc's most recent insider trade came on October 11, 2022 by Max Reinhardt who sold 1,380 units worth $80.04K . In the last 10 years, insiders at Pacira Pharmaceuticals, Inc have sold an estimated value of $407.94M and bought an estimated value of $120.24M worth of shares. Insider trading is most common in June, with the busiest year in 2013. The most active traders at the company are David Stack, CEO and Chairman,  Andreas Wicki, Director,  and Bullaro Lauren Riker, Senior Vice President .

Pacira BioSciences, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1